Vitix
/ York Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 29, 2022
Promiscuous activity of β-carotene hydroxylase CrtZ on epoxycarotenoids leads to the formation of rare carotenoids with 6-hydroxy-3-keto-ε-ends.
(PubMed, FEBS Lett)
- "We suggest that the reaction mechanism is similar to that of a rhodoxanthin biosynthetic enzyme. Our results provide further understanding of the reaction mechanism of diiron-containing β-carotene hydroxylases, as well as insight into the biosynthesis of natural compounds with 6-hydroxy-3-keto-ε-end carotenoid derivatives."
Journal
January 26, 2022
Phytoconstituents from Adenanthera pavonina L. as antioxidants and inhibitors of inducible TNF-α production in BV2 cells.
(PubMed, Nat Prod Res)
- "Tamarixetin 3-O-(α-ʟ-rhamnopyranosyl)-(1→2)-β-ᴅ-galactopyranoside (11), a previously undescribed compound, was the most effective at suppressing TNF-α protein and m-RNA levels. Other flavonoid glycosides, quercetin 3-O-(α-ʟ-rhamnopyranosyl-(1→2)-β-ᴅ-xylopyranoside (4), isovitixin (5), and quercetin-3-O-[α-ʟ-rhamnopyranosyl-(1→2)]-[α-ʟ-rhamnopyranosyl-(1→6)]-β-ᴅ-galactopyranoside (9), also significantly lowered TNF-α production."
Journal • Immunology • Inflammation • Oncology • TNFA
1 to 2
Of
2
Go to page
1